Tristan J Vaughan

This inventor holds 33 USPTO granted patents, plus 3 CIPO patents and 5 EPO patents, primarily in Human Antibody Development. Top assignees: Human Genome Sciences, Inc., Abbott Biotechnology Ltd., Cambridge Antibody Technology Limited. Active years: 1999-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tristan J Vaughan. Retrieved from https://idiyas.com/inventor/tristan-j-vaughan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 33

% Patents Active = 51.5

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 8)

Average Co-Inventor Count = 6.1

ph-index = 22

Forward Citations = 2,501(Granted Patents)

Location History:

Cambridgeshire, GB (2001)
Great Shelford, GB (2006)
Impington, GB (2000 - 2007)
Cambridge, GB (1999 - 2020)

Company Filing History:

9 out of 676

Human Genome Sciences, Inc.

patents

8 out of 17

Abbott Biotechnology Ltd.

patents

7 out of 28

Cambridge Antibody Technology Limited

Basf Aktiengesellschaft

patents

6. 1 out of 93

Abbvie Biotechnology Ltd

patents

7. 1 out of 259

Medical Research Council

patents

where one patent can have more than one assignee

Years Active: 1999-2020

Loading Chart...

Areas of Expertise:

Eotaxin

Human Antibodies

TNFα

Rheumatoid Arthritis

Cancer Treatment

B Lymphocyte Stimulator

TRAIL Receptors

Binding Members

Immunospecific Binding

Antibody Therapy

Molecule Labelling

Therapeutic Methods

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10829540 - Phage display library, members thereof and uses of the same (2020-11-10),

2. 10577413 - Human antibodies against eotaxin and their use (2020-03-03),

3. 9284589 - Methods of obtaining a specific binding member that binds eotaxin (2016-03-15),

4. 9187548 - Antibodies that immunospecifically bind to B lymphocyte stimulator protein (2015-11-17),

5. 8753633 - Human antibodies that bind human TNFα (2014-06-17),

6. 8715961 - Methods of obtaining a specific binding member that binds eotaxin (2014-05-06),

7. 8414894 - Human antibodies that bind human TNFα and methods of using same (2013-04-09),

8. 8372401 - Human antibodies that bind human TNFα (2013-02-12),

9. 8372400 - Methods of treating disorders using human antibodies that bind human TNFα (2013-02-12),

10. 8206714 - Methods for treating rheumatoid arthritis using human antibodies that bind human TNFa (2012-06-26),

11. 8197813 - Human antibodies that bind human TNFα (2012-06-12),

12. 8101181 - Antibodies that immunospecifically bind to B lymphocyte stimulator protein (2012-01-24),

13. 8067564 - Methods of obtaining a specific binding member that binds eotaxin (2011-11-29),

14. 7879328 - Antibodies that immunospecifically bind to B lymphocyte stimulator (2011-02-01),

15. 7605236 - Antibodies that immunospecifically bind to B lymphocyte stimulator protein (2009-10-20),

Title: The Innovative Mind of Tristan J Vaughan

Introduction: Tristan J Vaughan, a talented inventor hailing from Impington, GB, is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Tristan J Vaughan's latest patents include cutting-edge advancements in artificial intelligence algorithms for autonomous vehicles and smart home systems.

Career Highlights: With a career spanning over two decades, Tristan J Vaughan has established himself as a visionary in the tech industry. His work on renewable energy solutions and sustainable technologies has garnered international acclaim.

Collaborations: Tristan J Vaughan has collaborated with leading research institutions and tech companies to bring his inventions to life. His partnerships have led to the development of revolutionary products that have reshaped the way we interact with technology.

Conclusion: In conclusion, Tristan J Vaughan's passion for innovation and his relentless pursuit of excellence have solidified his position as a trailblazer in the world of technology. His inventive spirit continues to inspire the next generation of inventors and innovators.

Profile summary based on public USPTO records.